TOP 100 MEDICAL SITES
| |||
|
| |||
| |||
|
| |||
| Medco Makes Push Into Genetic Testing Medco is expanding its efforts to promote genetic tests that can signal how a person will react to a drug or to help decide what medicine is best. online.wsj.com |
Biotech: Update on Deals, Mergers, Funding The Burrill Report submits: By Marie DaghlianNutritional supplements may have passed their media heyday but they are still big business. This week private equity firm The Carlyle Group decided to beef up its portfolio by acquiring NBTY (NTY), a global nutritional supplements company that markets products under the names Nature's Bounty, Vitamin World, and Puritan's Pride, in a transaction valued at $3.8 billion. Carlyle, which has assets of more than $90.5 billion under management, will pay $55 per share in cash for all outstanding common shares of NBTY, representing a premium of approximately 57 percent over NBTY's average closing share price during the 30 trading days ended July 14, 2010. The transaction is expected to close by the end of 2010. The announcement triggered a 43 percent jump in NBTY’s shares to $53.74. Complete Story » seekingalpha.com |
Merck Reports Encouraging Results for Hepatitis C Treatment Merck & Co. said Wednesday the addition of its experimental hepatitis C drug to standard treatment improved patient outcomes in two clinical trials, compared with standard treatment alone. online.wsj.com |
J&J Is Faulted on Recall Timing Johnson & Johnson should have moved sooner to recall some Motrin pills that it discovered were defective in late 2008, a federal official said in prepared testimony. online.wsj.com |
Genzyme Corporation CEO Discusses Q3 2010 Earnings - Call Transcript Genzyme Corporation (GENZ)Q3 2010 Earnings CallOctober 20, 2010 11:00 am ETComplete Story » seekingalpha.com |